Catalogue numbers for GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile) | ||||||
---|---|---|---|---|---|---|
Catalogue Number | Stent Labeled/Nominal Diameter (mm) | Maximum Post-Dilated Stent Diameter (mm)* | Stent Length (mm) | Catheter Length (cm) | Guidewire Diameter (in) | Introducer Sheath Size (Fr) |
BXB051502E | 5 | 8 | 15 | 135 | .035 | 6 |
BXB051902E | 5 | 8 | 19 | 135 | .035 | 6 |
BXB052902E | 5 | 8 | 29 | 135 | .035 | 6 |
BXB053902E | 5 | 8 | 39 | 135 | .035 | 6 |
BXB055902E | 5 | 8 | 59 | 135 | .035 | 6 |
BXB057902E | 5 | 8 | 79 | 135 | .035 | 6 |
BXB061502E | 6 | 8 | 15 | 135 | .035 | 6 |
BXB061902E | 6 | 8 | 19 | 135 | .035 | 6 |
BXB062902E | 6 | 8 | 29 | 135 | .035 | 6 |
BXB063902E | 6 | 8 | 39 | 135 | .035 | 6 |
BXB065902E | 6 | 8 | 59 | 135 | .035 | 6 |
BXB067902E | 6 | 8 | 79 | 135 | .035 | 6 |
BXB071502E | 7 | 11 | 15 | 135 | .035 | 6 |
BXB071902E | 7 | 11 | 19 | 135 | .035 | 6 |
BXB072902E | 7 | 11 | 29 | 135 | .035 | 6 |
BXB073902E | 7 | 11 | 39 | 135 | .035 | 6 |
BXB075902E | 7 | 11 | 59 | 135 | .035 | 6 |
BXB077902E | 7 | 11 | 79 | 135 | .035 | 6 |
BXB082902E | 8 | 11 | 29 | 135 | .035 | 7 |
BXB083902E | 8 | 11 | 39 | 135 | .035 | 7 |
BXB085902E | 8 | 11 | 59 | 135 | .035 | 7 |
BXB087902E | 8 | 11 | 79 | 135 | .035 | 7 |
BXB092902E | 9 | 13 | 29 | 135 | .035 | 7 |
BXB093902E | 9 | 13 | 39 | 135 | .035 | 7 |
BXB095902E | 9 | 13 | 59 | 135 | .035 | 7 |
BXB097902E | 9 | 13 | 79 | 135 | .035 | 7 |
BXBL082902E | 8 | 16 | 29 | 135 | .035 | 7 |
BXBL083902E | 8 | 16 | 39 | 135 | .035 | 7 |
BXBL085902E | 8 | 16 | 59 | 135 | .035 | 8 |
BXBL087902E | 8 | 16 | 79 | 135 | .035 | 8 |
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis | ||||||
---|---|---|---|---|---|---|
Catalogue Number | Stent Labeled/Nominal Diameter (mm) | Maximum Post-Dilated Stent Diameter (mm)* | Stent Length (mm) | Catheter Length (cm) | Guidewire Diameter (in) | Introducer Sheath Size (Fr) |
BXA051502E | 5 | 8 | 15 | 135 | .035 | 7 |
BXA051902E | 5 | 8 | 19 | 135 | .035 | 7 |
BXA052902E | 5 | 8 | 29 | 135 | .035 | 7 |
BXA053902E | 5 | 8 | 39 | 135 | .035 | 7 |
BXA055902E | 5 | 8 | 59 | 135 | .035 | 7 |
BXA057902E | 5 | 8 | 79 | 135 | .035 | 7 |
BXA061502E | 6 | 8 | 15 | 135 | .035 | 7 |
BXA061902E | 6 | 8 | 19 | 135 | .035 | 7 |
BXA062902E | 6 | 8 | 29 | 135 | .035 | 7 |
BXA063902E | 6 | 8 | 39 | 135 | .035 | 7 |
BXA065902E | 6 | 8 | 59 | 135 | .035 | 7 |
BXA067902E | 6 | 8 | 79 | 135 | .035 | 7 |
BXA071502E | 7 | 11 | 15 | 135 | .035 | 7 |
BXA071902E | 7 | 11 | 19 | 135 | .035 | 7 |
BXA072902E | 7 | 11 | 29 | 135 | .035 | 7 |
BXA073902E | 7 | 11 | 39 | 135 | .035 | 7 |
BXA075902E | 7 | 11 | 59 | 135 | .035 | 7 |
BXA077902E | 7 | 11 | 79 | 135 | .035 | 7 |
BXA082902E | 8 | 11 | 29 | 135 | .035 | 7 |
BXA083902E | 8 | 11 | 39 | 135 | .035 | 7 |
BXA085902E | 8 | 11 | 59 | 135 | .035 | 7 |
BXA087902E | 8 | 11 | 79 | 135 | .035 | 8 |
BXA092902E | 9 | 13 | 29 | 135 | .035 | 8 |
BXA093902E | 9 | 13 | 39 | 135 | .035 | 8 |
BXA095902E | 9 | 13 | 59 | 135 | .035 | 8 |
BXA097902E | 9 | 13 | 79 | 135 | .035 | 8 |
BXA102902E | 10 | 13 | 29 | 135 | .035 | 8 |
BXA103902E | 10 | 13 | 39 | 135 | .035 | 8 |
BXA105902E | 10 | 13 | 59 | 135 | .035 | 8 |
BXA107902E | 10 | 13 | 79 | 135 | .035 | 8 |
BXA112902E | 11 | 16 | 29 | 135 | .035 | 8 |
BXA113902E | 11 | 16 | 39 | 135 | .035 | 8 |
BXA115902E | 11 | 16 | 59 | 135 | .035 | 8 |
BXA117902E | 11 | 16 | 79 | 135 | .035 | 8 |
BXAL082902E | 8 | 16 | 29 | 135 | .035 | 7 |
BXAL083902E | 8 | 16 | 39 | 135 | .035 | 7 |
BXAL085902E | 8 | 16 | 59 | 135 | .035 | 8 |
BXAL087902E | 8 | 16 | 79 | 135 | .035 | 8 |
* Secondary balloon required to post-dilate the stent beyond its nominal deployed diameter (secondary balloon not included).

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis:
INDICATIONS FOR USE IN EUROPE: The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of:
- de novo or restenotic lesions in the iliac arteries, including lesions at the aortic bifurcation;
- de novo or restenotic lesions in the visceral arteries;
- isolated visceral, iliac, and subclavian artery aneurysms; or
- traumatic or iatrogenic vessel injuries in arteries that are located in the chest cavity, abdominal cavity, or pelvis (except for aorta, coronary, innominate, carotid, vertebral, and pulmonary arteries).
The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for use as a bridging stent in branched and fenestrated endovascular aortic aneurysm repair with the following:
- Approved for use branched aortic endovascular grafts constructed of polyester fabric, stainless steel stents, and polypropylene suture with branch diameters of 6/8 mm and lengths of 18/21 mm.
- Approved for use fenestrated aortic endovascular grafts constructed of polyester fabric, stainless steel stents, and fenestrations with polypropylene suture ranging in diameter from 6–8 mm.
CONTRAINDICATIONS: Do not use the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II.
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile):
INDICATIONS FOR USE IN EUROPE: The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of:
- de novo or restenotic lesions in the iliac arteries, including lesions at the aortic bifurcation;
- de novo or restenotic lesions in the visceral arteries;
- isolated visceral, iliac, and subclavian artery aneurysms; or
- traumatic or iatrogenic vessel injuries in arteries that are located in the chest cavity, abdominal cavity, or pelvis (except for aorta, coronary, innominate, carotid, vertebral, and pulmonary arteries).
CONTRAINDICATIONS: Do not use the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II.